In January 2026, an AI startup called OpenEvidence closed a $250 million Series D funding round that doubled its valuation to approximately $12 billion. Here’s the remarkable part: the company has fewer than 100 employees. Founder and CEO Daniel Nadler believes this isn’t an anomaly—it’s the future of business.
What Is OpenEvidence?
OpenEvidence is an AI-powered medical information and clinical decision support platform used by physicians. It helps doctors access evidence-based medical information instantly, improving patient outcomes and reducing diagnostic errors.
The company’s core technology uses advanced AI to synthesize medical literature, clinical guidelines, and patient data to provide physicians with actionable insights at the point of care. It’s like having a medical research assistant that never sleeps, never forgets, and always has the latest information.
The $12 Billion Valuation
The recent funding round was co-led by Thrive Capital and DST Global—heavy hitters in the venture capital world. But what caught everyone’s attention wasn’t just the valuation. It was Nadler’s bold prediction about the future of work.
According to Fortune, Nadler stated during a panel at NVIDIA’s GTC 2026 summit: “In the coming years, some of the most valuable companies in the world will have ‘sub-100 employees.’ I think the world’s not prepared for that.”
How AI Enables Tiny Teams
OpenEvidence isn’t just a medical AI company. It’s a case study in what’s possible when you fully embrace AI automation. With under 100 employees, they’ve achieved what would have required thousands of workers a decade ago.
Here’s how they’re doing it:
- AI handles research synthesis — Millions of medical papers processed automatically
- AI manages customer support
- AI optimizes operations — Resource allocation, scheduling, and logistics automated
- AI assists with development — Code generation, testing, and deployment accelerated
The Healthcare AI Opportunity
OpenEvidence operates at the intersection of two massive trends: the AI healthcare revolution and the physician burnout crisis. Doctors are overwhelmed with information. Medical knowledge doubles every few months. Keeping current is impossible.
OpenEvidence solves this by giving physicians instant access to the collective medical knowledge of humanity. The AI doesn’t replace doctors—it augments them, making them more effective and confident in their decisions.
Lessons for Australian Businesses
The OpenEvidence story offers several lessons for Australian companies looking to leverage AI:
- Focus on high-value problems — Medical errors cost lives and billions of dollars. OpenEvidence addresses both.
- Embrace AI-native operations — Don’t just add AI to existing processes. Reimagine what’s possible.
- Prioritize quality over headcount — A small team of exceptional people with AI tools outperforms a large mediocre team.
- Think globally from day one — AI enables you to serve customers worldwide without local offices.
At aideveloper.com.au, we help Australian businesses implement similar AI strategies. Our AI business audit identifies opportunities to reduce headcount while increasing output.
The Sub-100 Employee Future
Nadler’s prediction isn’t just speculation. We’re already seeing it across industries:
- Midjourney — Billion-dollar valuation, ~40 employees
- Instagram — Sold for $1B with 13 employees
- WhatsApp — Sold for $19B with 55 employees
AI is accelerating this trend. Companies that embrace AI can achieve massive scale with minimal headcount. Those that don’t will be outcompeted by leaner, AI-native rivals.
What This Means for Workers
The sub-100 employee trend raises important questions about the future of work. If the most valuable companies need fewer people, what happens to employment? Nadler’s view is optimistic: AI will create new types of jobs we can’t yet imagine, just as the internet did.
For individuals, the implication is clear: develop skills that complement AI rather than compete with it. Become the person who can leverage AI to achieve extraordinary results.
Building Your Own OpenEvidence
You don’t need $250 million in funding to apply OpenEvidence’s principles. Start by asking:
- What high-value problem can I solve with AI?
- How can I automate 80% of my operations?
- What would my business look like if I could only have 10 employees?
The answers might surprise you. The tools are available. The opportunity is massive. The only question is whether you’ll seize it.
Interested in building an AI-native business? Contact us to discuss how we can help you achieve more with less.
